Home >> Clinical Trials News Archive >> 2012 >> Oct 2012
A course on
Regulatory Strategies and Compliance in the Development of Drugs & Biotechnology-Derived Products
will be held at in,Ramat-Gan on 29 November, 06, 20 and 27 December 2012. The instructor is Dr. Moshe Neuman, PhD, CEO & President of B.R.D.– Bio Medical Research Design Ltd.
Q3 biotech venture investing makes a boisterous leap.
The life sciences industry gained a blast of good news on the venture front today. The National Venture Capital Association and PricewaterhouseCoopers outlined a buoyant set of numbers for the industry, noting a nice spike in the amount invested in biotechs as well as the number of deals completed.
The 10th Go4Europe Conference will be held on October 29th at the Hilton Tel Aviv.
Organized by Cukierman Investment House Ltd. and Catalyst Fund, Go4Europe is one of the most prestigious business conferences in Israel, addressing the current issues of raising funds and establishing strategic alliances in Europe. A major part of the conference is focused on the Hi-Tech, Biotech, and Greentech industries.
Yissum Technology Transfer Company of the Hebrew University of Jerusalem has raised $7 million for its new biotechnology unit, Integra Holdings Ltd.,
at a company value of $25 million, before money. Israeli investment institutions and Invatech, a group of US and Israeli investors, made the investment.